Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Posterior Fossa Ependymal Tumor × Specimen Handling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 28 Lung Neoplasms 26 Carcinoma, Non-Small-Cell Lung 25 Leukemia, Myeloid, Acute 20 Multiple Myeloma 17 Breast Neoplasms 17 Urinary Bladder Neoplasms 13 Lymphoma 13 Carcinoma, Renal Cell 13 Lymphoma, Large B-Cell, Diffuse 12 Neoplasm Metastasis 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Pancreatic Neoplasms 10 Myelodysplastic Syndromes 10 Squamous Cell Carcinoma of Head and Neck 9 Mouth Neoplasms 9 Glioma 9 Glioblastoma 9 Colorectal Neoplasms 9 Sarcoma 8 Ovarian Neoplasms 8 Myeloproliferative Disorders 8 Triple Negative Breast Neoplasms 7 Melanoma 7 Leukemia, Myelomonocytic, Chronic 7 Laryngeal Neoplasms 7 Carcinoma 7 Burkitt Lymphoma 7 Wilms Tumor 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

Specimen Handling 1 Metformin 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07226453 2026-03-13

PNOC041

University of California, San Francisco

Phase 2 Recruiting

Posterior Fossa Ependymal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡